PR Newswire
Sen-Jam Pharmaceutical Secures Major Strategic Partnership with TASK Clinical to Fund Two-Thirds of Phase 3 Trial for SJP-001
📈
AI Sentiment
Highly Positive
8/10
- Home
- TAK
as of 12-15-2025 3:36pm EST
$14.57
+$0.25
+1.75%
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Chart Type:
Time Range:
| Founded: | 1781 | Country: | Japan |
| Employees: | N/A | City: | N/A |
| Market Cap: | 43.3B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Semi-Annual | |
| EPS: | 0.14 | EPS Growth: | -88.67 |
| 52 Week Low/High: | $12.80 - $15.69 | Next Earning Date: | 01-29-2026 |
| Revenue: | $29,846,840,032 | Revenue Growth: | -2.84% |
| Revenue Growth (this year): | -0.3% | Revenue Growth (next year): | 0.59% |
AI-Powered TAK Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 77.12%
77.12%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of) News
TAK Breaking Stock News: Dive into TAK Ticker-Specific Updates for Smart Investing
PR Newswire
Sen-Jam Pharmaceutical Appoints Global Life Sciences Leader Rute Fernandes as Executive Advisor to Accelerate Commercialization Pathways
📈
AI Sentiment
Highly Positive
8/10
Compare TAK vs Leading Stocks
See how TAK stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.